Seguir
Andreia Goncalves
Andreia Goncalves
Scientist/Senior Scientist, Johnson & Johnson Innovative Medicine, San Francisco, USA
Email confirmado em its.jnj.com
Título
Citado por
Citado por
Ano
Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals
C Marques, C Mega, A Gonçalves, P Rodrigues-Santos, ...
Mediators of inflammation 2014, 2014
1472014
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood–retinal barrier in a type 2 diabetes animal model
A Gonçalves, E Leal, A Paiva, E Teixeira Lemos, F Teixeira, CF Ribeiro, ...
Diabetes, Obesity and Metabolism 14 (5), 454-463, 2012
1032012
Regulation of claudins in blood-tissue barriers under physiological and pathological states
A Gonçalves, AF Ambrósio, R Fernandes
Tissue barriers 1 (3), e24782, 2013
912013
Dipeptidyl peptidase-IV inhibition prevents blood–retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats
A Gonçalves, C Marques, E Leal, CF Ribeiro, F Reis, AF Ambrósio, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014
802014
Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood–retinal barrier breakdown and inflammation
A Gonçalves, CM Lin, A Muthusamy, C Fontes-Ribeiro, AF Ambrósio, ...
Investigative ophthalmology & visual science 57 (6), 2584-2592, 2016
592016
Organ-on-a-chip technologies for advanced blood–retinal barrier models
H Ragelle, A Goncalves, S Kustermann, DA Antonetti, A Jayagopal
Journal of Ocular Pharmacology and Therapeutics 36 (1), 30-41, 2020
352020
The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation
A Gonçalves, L Almeida, AP Silva, C Fontes-Ribeiro, AF Ambrósio, ...
Biomedicine & Pharmacotherapy 102, 833-838, 2018
232018
The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes
C Marques, A Gonçalves, PMR Pereira, D Almeida, B Martins, ...
Life sciences 234, 116738, 2019
192019
Vascular expression of permeability-resistant occludin mutant preserves visual function in diabetes
A Goncalves, A Dreffs, C Lin, S Sheskey, N Hudson, J Keil, M Campbell, ...
Diabetes 70 (7), 1549-1560, 2021
152021
Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin
A Goncalves, EJ Su, A Muthusamy, M Zeitelhofer, D Torrente, I Nilsson, ...
Blood, The Journal of the American Society of Hematology 140 (4), 388-400, 2022
122022
Transgenic animal models to explore and modulate the blood brain and blood retinal barriers of the CNS
A Goncalves, DA Antonetti
Fluids and barriers of the CNS 19 (1), 86, 2022
102022
Regulation of intracellular heme modulates retinal angiogenesis
A Goncalves, X Liu, N Santander, T Arnold, DA Antonetti
Investigative Ophthalmology & Visual Science 63 (7), 3178–F0452-3178–F0452, 2022
2022
Endothelial expression of permeability-resistant occludin mutant preserves visual function in diabetes
C Lin, A Goncalves, JM Keil, S Sheskey, DA Antonetti
Investigative Ophthalmology & Visual Science 60 (9), 2692-2692, 2019
2019
Exendin-4, a glucagon-like peptide 1 receptor agonist, reduces retinal vascular permeability and prevents microglia activation in type 1 diabetes
RC Fernandes, A Goncalves, L Costa, MI Barros, C Gomes, ...
GLIA 67, E239-E239, 2019
2019
Contribution of occludin S490 phosphorylation on blood retinal barrier integrity and visual function.
A Goncalves, J Keil, S Sheskey, C Lin, D Antonetti
Investigative Ophthalmology & Visual Science 59 (9), 3008-3008, 2018
2018
Exendin-4, a glucagon-like peptide 1 analog, prevents the increase in blood-retinal barrier permeability and microglia activation in a type 1 diabetes animal model
A Goncalves, MI Barros, J Martins, CA Gomes, C Fontes-Ribeiro, ...
GLIA 65, E506-E507, 2017
2017
Para além da PMA... A investigação científica com embriões
AF Gonçalves
Para além da PMA... A investigação científica com embriões, 2017
2017
Can DPP-IV Inhibitors or GLP-1 Analogs Be Tomorrow’s Therapy for Diabetic Retinopathy?
AFD Gonçalves
PQDT-Global, 2016
2016
AMELIORATION OF KIDNEY INFLAMMATION AND APOPTOTIC CELL DEATH IN AN ANIMAL MODEL OF TYPE 2 DIABETES
C Marques, C Mega, A Goncalves, P Rodrigues-Santos, ...
NEPHROLOGY DIALYSIS TRANSPLANTATION 29, 174-174, 2014
2014
DIABETES EXPERIMENTAL
C Marques, C Mega, A Gonçalves, P Rodrigues-Santos, ...
Nephrology Dialysis Transplanation 29 (suppl_3), 2014
2014
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20